British Journal of Radiology · 2019 · 25 citations · 17 references
MedicineOncologyRadiologyDiagnostic RadiologySurgical OncologyTumor PathologyBone PathologyBone Tumor ImagingBone TumorsMalignant TumorsSkull Base ImagingSkull Base TumorsBone Extracellular Matrix MineralizationMatrix MineralizationOsteosarcoma ImagingSkull Base InvasionSkull Base InvolvementSkull Base MalignanciesSkull Base Tumor ImagingTumor Matrix Assessment
Objective: This study aims to assess the CT and MRI features of calvarium and skull base osteosarcoma (CSBO). Methods: The CT and MRI features and pathological characteristics of 12 cases of pathologically confirmed CSBO were analyzed retrospectively. Results: 12 patients (age range 9–67 years; 3 male, 9 female) were included in the study. Tumours occurred in skull base (7, 58.3%), temporal (4, 33.3%) and frontal (1, 8.3%). Among all, six patients received radiotherapy for nasopharyngeal carcinoma. According to pathology, 11 out of 12 tumours were high-grade (91.7%). On CT, all the tumours had soft tissue mass penetrated into cortical bone with invasion of surrounding soft tissue. Six tumours were shown to have lytic density and six were mixed density. Matrix mineralization was present in 10 cases (83.3%). On MRI, tumours presented as soft-tissue masses measuring 5.9 ± 2.4 (3.9–8.0) cm. Five tumours showed low signal intensities on T 1 weighted imaging with seven having heterogeneous signal intensities. One showed low signal intensity on T 2 weighted imaging, two showed high signal intensities and nine heterogeneous signal intensities. All the tumours showed low signal intensities on diffusion-weighted imaging. On contrast enhanced images, seven cases showed heterogeneous enhancement, three showed peripheral enhancementand and two showed homogeneous enhancement. Dural tail sign were detected in nine cases. Conclusion: CSBO is rare, and is commonly associated with previous radiation exposure. A presumptive diagnosis for osteosarcoma should be considered when calvarium and skull base tumours with osteoid matrix and duraltail sign are found. Advances in knowledge: CT and MR features of CSBO have not been reported. The study helps to identify CSBO and other sarcomas.
17
The many faces of osteosarcoma.
Mark D. Murphey, Mark Robbin, Gerald McRae et al. · Radiographics · 1997 · 283 citations
Michael Parry, Minna Laitinen, José I. Albergo et al. · The Bone & Joint Journal · 2016 · 152 citations
Osteosarcomas of the skull. Clinical remarks on 19 cases
Maurizio Salvati, Pasquale Ciappetta, Antonino Raco · Cancer · 1993 · 94 citations
Medicine, Neurosurgery, Oncology +17
Chemotherapy in head and neck osteosarcoma: Adjuvant chemotherapy improves overall survival
Yiming Chen, Sandhya Gokavarapu, Qingcheng Shen et al. · Oral Oncology · 2017 · 63 citations
Medicine, Oncology, Pharmacology +12